Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives
- PMID: 16182408
- DOI: 10.1016/j.addr.2005.07.009
Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives
Abstract
Nasal drug delivery has now been recognized as a very promising route for delivery of therapeutic compounds including biopharmaceuticals. It has been demonstrated that low absorption of drugs can be countered by using absorption enhancers or increasing the drug residence time in the nasal cavity, and that some mucoadhesive polymers can serve both functions. This article reviews the background of nasal mucoadhesive drug delivery with special references to the biological and pharmaceutical considerations for nasal mucoadhesive drug administration. Applications of nasal mucoadhesives for the delivery of small organic molecules, antibiotics, proteins, vaccines and DNA are also discussed. Furthermore, new classes of functionalized mucoadhesive polymers, the characterization and safety aspects of nasal drug products as well as the opportunities presented by nasal drug delivery are extensively discussed.
Similar articles
-
The application of mucoadhesive polymers in nasal drug delivery.Drug Dev Ind Pharm. 2010 Mar;36(3):323-36. doi: 10.1080/03639040903170750. Drug Dev Ind Pharm. 2010. PMID: 19735210 Review.
-
Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.Eur J Pharm Sci. 2007 Dec;32(4-5):296-307. doi: 10.1016/j.ejps.2007.08.006. Epub 2007 Aug 31. Eur J Pharm Sci. 2007. PMID: 17920822
-
Recent trends in drug delivery systems: intranasal drug delivery.Indian J Exp Biol. 1999 Jan;37(1):6-16. Indian J Exp Biol. 1999. PMID: 10355359 Review.
-
Mucoadhesive drug delivery systems.Handb Exp Pharmacol. 2010;(197):251-66. doi: 10.1007/978-3-642-00477-3_9. Handb Exp Pharmacol. 2010. PMID: 20217533 Review.
-
Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.Crit Rev Ther Drug Carrier Syst. 1994;11(2-3):119-60. Crit Rev Ther Drug Carrier Syst. 1994. PMID: 7600586 Review.
Cited by
-
Synthesis, characterization, and immune efficacy of layered double hydroxide@SiO2 nanoparticles with shell-core structure as a delivery carrier for Newcastle disease virus DNA vaccine.Int J Nanomedicine. 2015 Apr 13;10:2895-911. doi: 10.2147/IJN.S76312. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25926734 Free PMC article.
-
Noninvasive routes of proteins and peptides drug delivery.Indian J Pharm Sci. 2011 Jul;73(4):367-75. doi: 10.4103/0250-474X.95608. Indian J Pharm Sci. 2011. PMID: 22707818 Free PMC article.
-
Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders.Biomedicines. 2022 Jul 14;10(7):1706. doi: 10.3390/biomedicines10071706. Biomedicines. 2022. PMID: 35885011 Free PMC article. Review.
-
Simulation of drug transport in airway surface liquid considering mucus flow and ciliary interaction.Sci Rep. 2025 Aug 30;15(1):31951. doi: 10.1038/s41598-025-16822-8. Sci Rep. 2025. PMID: 40883423 Free PMC article.
-
Pharmacokinetics of intranasal crushed OxyContin and intravenous oxycodone in nondependent prescription opioid abusers.J Clin Pharmacol. 2012 Apr;52(4):600-6. doi: 10.1177/0091270011401620. Epub 2011 May 24. J Clin Pharmacol. 2012. PMID: 21610203 Free PMC article. Clinical Trial. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources